Dr. Vincent Dammai MS, MBA, MPH, PhD
A Molecular, Cell and Developmental Biologist, Dr. Dammai worked in academia for more than 14 years, first at Salk Institute for Biological Studies and later at University of California San Diego, followed by 11-years at the National Cancer Institute (NCI)-designated Hollings Cancer Center, Charleston as a NIH/NCI funded College of Medicine faculty. Dr.Dammai's MPH thesis was in neurobiology (epilepsy research) and his PhD thesis was in design and pre-clinical testing of catalytic RNA molecules (ribozymes) as a RNA-based therapeutics for rheumatoid arthritis (RA). Dr.Dammai's research unit at the Hollings Cancer Center focused on cancer diagnosis and treatment, involving biomarker discovery and selective targeting of therapeutic molecules to tumor sites, examples of some of the BIOLOGICS based technologies Dr.Dammai's laboratory developed. Dr.Dammai's research group discovered novel mechanisms of metastasis suppression and mechanisms of receptor tyrosine kinase activation. Examples of other technology development projects include activation of immune recognition for clearance of aggressive tumors and blockade of cancer metastasis through targeting a novel mis-sorted intracelluar protein complex. Dr.Dammai's focus through these studies is to develop novel RNA- and Protein-based BIOLOGICS and tissue-specific delivery systems to address a variety of human diseases. Dr.Dammai served as an ad hoc reviewer and editorial board member for multiple top-tier science journals. While in academia, his university roles included faculty senator, institutional advancement committee, advisory committee for Cancer Proteomics, advisory committee for Biological imaging core facility, and Director and co-Director of PhD and MD/PhD programs in Molecular and Cell Biology. He served as a translational medicine grant reviewer for a number of years for the American Cancer Society (ACS), Department of Defense (DOD), National Aeronautics and Space Administration (NASA) and for the Italian Ministry of Health, Italy. Dr.Dammai has an exceptional breadth of knowledge in diverse fields of biomedical sciences and bioengineering, and technology collaborations with multiple biotech companies. He is published in top-tier journals such as: Genes & Development, CELL, Nature Cell Biology, Gene Therapy, Cancer Research, Molecular & Cellular Biology and Journal of Biological Chemistry. Dr.Dammai is CEO and President of Dammai-Morgan Scientific Consultants. Dr.Dammai also serves as President/CEO of Biosimilars & Biologics Inc., a venture initially promoted by DMSC. Pubmed Publications
Dammai-Morgan Scientific Consultants LLC partners with a worldwide network of eminent scientists to develop innovative solutions to research problems. Our talent pool is the main force of innovation and responsive to clients' unique needs.